Mesoblast (MESO) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $161.6 million.
- Mesoblast's Cash & Equivalents rose 15667.09% to $161.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $161.6 million, marking a year-over-year increase of 15667.09%. This contributed to the annual value of $161.6 million for FY2025, which is 15667.09% up from last year.
- According to the latest figures from Q2 2025, Mesoblast's Cash & Equivalents is $161.6 million, which was up 15667.09% from $38.0 million recorded in Q4 2024.
- In the past 5 years, Mesoblast's Cash & Equivalents registered a high of $161.6 million during Q2 2025, and its lowest value of $38.0 million during Q4 2024.
- In the last 5 years, Mesoblast's Cash & Equivalents had a median value of $77.2 million in 2022 and averaged $89.8 million.
- Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 16343.36% in 2021, then crashed by 5583.97% in 2022.
- Quarter analysis of 5 years shows Mesoblast's Cash & Equivalents stood at $94.8 million in 2021, then dropped by 28.71% to $67.6 million in 2022, then increased by 14.69% to $77.6 million in 2023, then crashed by 50.96% to $38.0 million in 2024, then surged by 324.94% to $161.6 million in 2025.
- Its Cash & Equivalents stands at $161.6 million for Q2 2025, versus $38.0 million for Q4 2024 and $63.0 million for Q2 2024.